Zeo ScientifiX Files 8-K: "Other Events" Reported

Ticker: ZEOX · Form: 8-K · Filed: Sep 20, 2024 · CIK: 1557376

Sentiment: neutral

Topics: 8-K, regulatory-filing, other-events

TL;DR

Zeo ScientifiX filed an 8-K for "Other Events" on 9/20/24 - details TBD.

AI Summary

Zeo ScientifiX, Inc. (formerly Organicell Regenerative Medicine, Inc.) filed an 8-K on September 20, 2024, reporting "Other Events." The filing does not contain specific details about the nature of these events, dollar amounts, or definitive dates beyond the filing date itself.

Why It Matters

This filing indicates a material event has occurred for Zeo ScientifiX, Inc., but the lack of specific details leaves investors uncertain about the nature and impact of these "Other Events."

Risk Assessment

Risk Level: medium — The filing is an 8-K for "Other Events" without specific details, creating uncertainty and potential risk for investors.

Key Players & Entities

FAQ

What specific "Other Events" are being reported by Zeo ScientifiX, Inc. in this 8-K filing?

The filing does not specify the nature of the "Other Events" beyond listing it as the item information.

When was the earliest event reported in this filing?

The earliest event reported was on September 20, 2024.

What is the principal executive office address for Zeo ScientifiX, Inc.?

The principal executive office is located at 3321 College Avenue, Suite 246, Davie, Florida 33314.

What was Zeo ScientifiX, Inc. formerly known as?

Zeo ScientifiX, Inc. was formerly known as Organicell Regenerative Medicine, Inc., Biotech Products Services & Research, Inc., and Bespoke Tricycles Inc.

What is the SIC code for Zeo ScientifiX, Inc.?

The Standard Industrial Classification (SIC) code is 2836 for Biological Products (No Diagnostic Substances).

Filing Stats: 1,271 words · 5 min read · ~4 pages · Grade level 14.8 · Accepted 2024-09-20 16:15:24

Key Financial Figures

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: September 20, 2024 ZEO SCIENTIFIX, INC. By: /s/ Ian T. Bothwell Ian T. Bothwell, Interim Chief Executive Officer and Chief Financial Officer 3

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing